Show simple item record

Serologic Evaluations of Hepatitis B and C Among Hemodialysis patients Nephrology Center of Benghazi

dc.contributor.authorAlzwei, Abdulkhaliq Omer
dc.date.accessioned2019-06-25T09:08:16Z
dc.date.available2019-06-25T09:08:16Z
dc.date.issued2019-03-12
dc.identifier.urihttp://repository.limu.edu.ly/handle/123456789/974
dc.descriptionThe introduction of HBV vaccination ,isolation of HBV seropositive patients and the use of dedicated dialysis machines and regular procedure for controlling the HBV infections dramatically reduces the spread of HBV infections among HD patients The prevalence of HCV infections among HD is high and varies between countries (2% to 60%) and even between dialysis units within a single country ,Dual infections more aggressive liver disease there are very few reports on the prevalence of such dual infections in hemodialysis patients.en_US
dc.language.isoenen_US
dc.publisherfaculty of Basic Medical Science - Libyan International Medical Universityen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleSerologic Evaluations of Hepatitis B and C Among Hemodialysis patients Nephrology Center of Benghazien_US
dc.typeOtheren_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States